
Previewing Key Myeloma Presentations to Watch at EHA 2026: With Joshua Richter, MD
Joshua Richter, MD, previews some of the most anticipated multiple myeloma presentations ahead of the 2026 EHA Congress.
Welcome to OncLive On Air®! I'm your host today, Chris Ryan
OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.
In today’s episode, we welcomed Joshua Richter, MD, to preview some of
In the exclusive interview, Dr Ricther highlighted some of the key abstracts he’s looking forward to seeing presented at EHA 2026, including primary data from an additional study of a bispecific antibody–based combination being evaluated in the early-relapse setting and longer-term analyses from pivotal phase 3 studies. Richter also shared the key themes and trends he expects to see during the meeting in Stockholm, Sweden.
_____
That’s all we have for today! Thank you for listening to this episode of OncLive On Air. Check back throughout the week for exclusive interviews with leading experts in the oncology field.
For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.
OncLive is also on social media. On X and BlueSky, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.
If you liked today’s episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!
Thanks again for listening to OncLive On Air.
*OncLive On Air is available on: Apple Podcasts, Spotify, CastBox, Podcast Addict, Podchaser, RadioPublic, and TuneIn.



















